Coordinated health coaching is associated with improved diabetes outcomes with lower cost vs. traditional diabetes management. Diabetes Health Partnership (DHP) is a telephonic coaching program designed to empower individuals with diabetes. This 12-month, observational, self-controlled multi-site study combined retrospective (6 mth pre-baseline) and prospective (6 mth post-baseline) data to assess the impact of the DHP program on A1C among 57 individuals with type 1 and type 2 diabetes. Mean change from baseline A1C (8.4±1.1%) was significant (-0.5 ± 0.9%, <0.0001) within the full cohort (n=54) but notable differences in A1C between Responders (n=27, ≥0.5% reduction) vs. Non-Responders (n=27, <0.5% reduction) were observed (Figure 1), with comparable medication changes with the exception of insulin. Differences in A1C between Responders and Non-Responders may be explained by a combination of differences in baseline A1C (8.5 ± 0.8% vs. 8.3 ± 1.2%), baseline body weight (191.2 ± 36.6 lbs vs. 201 ± 42.9 lbs) and change in body weight (-5.0 ± 10.1 lbs vs. 0.6 ± 6.7 lbs). Notably more Responders than Non-Responders had >3 coaching sessions focused on diet/nutrition (9 vs. 3, respectively). Participation in the DHP program was associated with clinically-significant improvements in glycemic control in many individuals with suboptimally controlled diabetes.


W.C. Biggs: Consultant; Self; Roche Diabetes Care. Research Support; Self; Dexcom, Inc., Gan & Lee Pharmaceuticals, Mylan, Novo Nordisk A/S, Sanofi US. A. Buskirk: Employee; Self; Roche Diabetes Care. L. Borsa: None. M.R. Lyden: None. C. Parkin: Consultant; Self; Abbott, CeQur Corporation, Dexcom, Inc., DreaMed Diabetes, Novo Nordisk Inc., Onduo, Roche Diabetes Care, Valeritas, Inc. B. Petersen: Employee; Self; Roche Diabetes Care.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at